Two generations of "gold standards": The impact of a decade in hepatitis e virus testing innovation on population seroprevalence

American Journal of Tropical Medicine and Hygiene

Volumn 93, Issue 4, 2015, Pages 714-717

  Kmush, Brittany L ^a   Labrique, Alain B ^a   Dalton, Harry R ^b   Ahmed, Zabed B ^c   Ticehurst, John R ^a,d   Heaney, Christopher D ^a   Nelson, Kenrad E ^a   Zaman, Khalequ ^e  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^c DHAKA SHISHU HOSPITAL   (Bangladesh)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Children's Nutrition Unit   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS E ANTIBODY; IMMUNOGLOBULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BANGLADESH; CHILD; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELISA KIT; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GOLD STANDARD; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNOASSAY ANALYZER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONHUMAN; PREDICTIVE VALUE; PRESCHOOL CHILD; REPEAT PROCEDURE; SEROEPIDEMIOLOGY; SEROPREVALENCE; VERY ELDERLY; WALTER REED ARMY INSTITUTE OF RESEARCH ASSAY; WANTAI ASSAY; AGE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BANGLADESH; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84943548462     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.15-0159     Document Type: Article

References (18)

1. Rein DB, Stevens G, Theaker J, Wittenborn JS, Wiersma ST, 2012. The global burden of hepatitis E virus. Hepatology 55: 988-997.
2. Seriwatana J, Shrestha MP, Scott RM, Tsarev SA, Vaughn DW, Myint KS, Innis BL, 2002. Clinical and epidemiological relevance of quantitating hepatitis E virus-specific immunoglobulin M. Clin Diagn Lab Immunol 9: 1072-1078.
3. Myint KS, Endy TP, Gibbons RV, Laras K, Mammen MP Jr, Sedyaningsih ER, Seriwatana J, Glass JS, Narupiti S, Corwin AL, 2006. Evaluation of diagnostic assays for hepatitis E virus in outbreak settings. J Clin Microbiol 44: 1581-1583.
4. Innis BL, Seriwatana J, Robinson RA, Shrestha MP, Yarbough PO, Longer CF, Scott RM, Vaughn DW, Myint KS, 2002. Quantitation of immunoglobulin to hepatitis E virus by enzyme immunoassay. Clin Diagn Lab Immunol 9: 639-648.
5. Labrique AB, Zaman K, Hossain Z, Saha P, Yunus M, Hossain A, Ticehurst J, Kmush B, Nelson KE, 2013. An exploratory case control study of risk factors for hepatitis E in rural Bangladesh. PLoS One 8: e61351.
6. Li RC, Ge SX, Li YP, Zheng YJ, Nong Y, Guo QS, Zhang J, Ng MH, Xia NS, 2006. Seroprevalence of hepatitis E virus infection, rural southern People's Republic of China. Emerg Infect Dis 12: 1682-1688.
7. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H, 2010. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 82: 799-805.
8. Mansuy JM, Bendall R, Legrand-Abravanel F, Saune K, Miedouge M, Ellis V, Rech H, Destruel F, Kamar N, Dalton HR, Izopet J, 2011. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 17: 2309-2312.
9. Mansuy JM, Legrand-Abravanel F, Calot JP, Peron JM, Alric L, Agudo S, Rech H, Destruel F, Izopet J, 2008. High prevalence of anti-hepatitis E virus antibodies in blood donors from south west France. J Med Virol 80: 289-293.
10. van Ginniken J, Bairagi R, de Francisco A, 1998. Health and Demographic Surveillance in Matlab: Past, Present and Future. Dhaka, Bangladesh: icddr,b special publication no. 72
11. Labrique AB, Zaman K, Hossain Z, Saha P, Yunus M, Hossain A, Ticehurst J, Nelson KE, 2009. Population seroprevalence of hepatitis E virus antibodies in rural Bangladesh. Am J Trop Med Hyg 81: 875-881.
12. Labrique AB, Zaman K, Hossain Z, Saha P, Yunus M, Hossain A, Ticehurst JR, Nelson KE, 2010. Epidemiology and risk factors of incident hepatitis E virus infection in rural Bangladesh. Am J Epidemiol 172: 952-961.
13. StataCorp, 2009. Stata Statistical Software. College Station, TX; StataCorp.
14. Verghese VP, Robinson JL, 2014. A systematic review of hepatitis E virus infection in children. Clin Infect Dis 59: 689-697.
15. Labrique AB, Kuniholm MH, Nelson KE, 2010. The global impact of hepatitis E: new horizons for an emerging virus. Scheld WM, Grayson ML, Hughes JM, eds. Emerging Infections, 9th edition. Washington, DC: ASM Press, 53-93.
16. Halliday JS, Harrison GL, Brown A, Hunter JG, Bendall R, Penny D, Toatu T, Abdad MY, Klenerman P, Barnes E, Dalton HR, 2014. Hepatitis E virus infection, Papua New Guinea, Fiji, and Kiribati, 2003-2005. Emerg Infect Dis 20: 1057-1058.
17. Dalton HR, Fellows HJ, Gane EJ, Wong P, Gerred S, Schroeder B, Croxson MC, Garkavenko O, 2007. Hepatitis E in New Zealand. J Gastroenterol Hepatol 22: 1236-1240.
18. Kmush B, Wierzba T, Krain L, Nelson K, Labrique AB, 2013. Epidemiology of hepatitis E in low-and middle-income countries of Asia and Africa. Semin Liver Dis 33: 15-29.